Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as 100,000+ Patients Seek Affordable Semaglutide...
A closer look at the artistry, technique, and philosophy behind Dr. Jindal's most sought-after transformation. TORONTO, ON / ACCESS Newswire...
The Best Scar Removal Cream for C-Section is Scar Protocol. SEATTLE, WA / ACCESS Newswire / December 19, 2025 /...
The Best Scar Removal Cream for C-Section is Scar Protocol. SEATTLE, WA / ACCESS Newswire / December 19, 2025 /...
Built on Google Cloud infrastructure, Drive Health is expanding Avery's clinical workflow and operational capabilities, building toward broader health system...
LONDON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- With office parties, cocktails with friends and end-of-year celebrations in full swing, many...
DynaMedex expansion will deliver an integrated AI workflow that combines expert clinician-reviewed evidence with authoritative medication intelligence in a single...
6-month commercial pilot demonstrated increasing demand among prescribersExpansion plan includes doubling the number of sales reps, a new GoodRx partnership,...
SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP)...
-- BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and...
U.S. Losartan market totals $245M annually with 71M prescriptions COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC....
U.S. Losartan market totals $245M annually with 71M prescriptions COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC....
Collaboration Advances CMS Health Tech Ecosystem Goals by Enabling Seamless, Secure Access to Health Data for Personalized Chronic Disease Management...
Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN...
From trending products like light therapy devices, baby health monitors, and wearable diagnostic trackers, use FSA funds to gift health...
Dr. Ember Ewings provides insight into modern mommy makeover planning, emphasizing personalized treatment, realistic expectations, and long-term results for patients...
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused...
The company will showcase a wave of transformative innovations designed to address the most pressing challenges in healthcare, spanning the...
KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available in the United...
The PRIME study, one of the largest studies on preterm birth, has been accepted for publication by a medical journal...